Literature DB >> 6398598

IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.

B Schwerer, H C Meeker, G Sersen, W R Levis.   

Abstract

Serum IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid I (PG) were determined in 121 leprosy patients, in contacts and controls by an enzyme-linked immunosorbent assay technique. Anti-PG IgM levels correlated with disease classification, increasing from the tuberculoid towards the lepromatous pole of the disease spectrum. There was a linear correlation between serum IgM PG-antibody levels and bacillary index (BI), a measure of bacterial load. Elevated anti-PG IgM in bacillary negative patients was usually indicative of active disease, undetected by BI. We conclude that anti-PG IgM levels are valuable for monitoring the degree of disease activity. Serum anti-PG IgM levels were significantly lower in patients with erythema nodosum leprosum (ENL) as compared to those without ENL, suggesting that IgM PG-antibodies are also involved in the pathogenesis of ENL.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6398598

Source DB:  PubMed          Journal:  Acta Leprol        ISSN: 0001-5938


  3 in total

1.  Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.

Authors:  W R Levis; H C Meeker; G B Schuller-Levis; T P Gillis; L J Marino; J Zabriskie
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

2.  Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.

Authors:  Rupendra Jadhav; Lavanya Suneetha; Ravindra Kamble; Vidyagouri Shinde; Karuna Devi; Meher Vani Chaduvula; Renuka Raju; Sujai Suneetha; Peter G Nicholls; Wim H van Brakel; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

Review 3.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.